MedTrace Logo

Comparison Between Bupivacaine and Bupivacaine- Dexamethasone QLB for Postoperative Analgesia

NCT05918796 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-08-24

No results posted yet for this study

Summary

The objective of this study is to assess the analgesic sparing effect of adding Dexamethasone to Bupivacaine in Quadratus lumborum block in patients undergoing Laparoscopic cholecystectomy under general anesthesia.

Conditions

  • Post Operative Pain

Interventions

DRUG

Bupivacaine

18 ml of bupivacaine of 0.25% injected bilaterally in quadratus lumborum block

DRUG

Dexamethasone

dexamethasone

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • rasha g abusinna, MD · Faculty of medicine Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-15
Primary Completion
2023-08-01
Completion
2023-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05918796 on ClinicalTrials.gov